Lilly's experimental drug cuts weight by 21% in diabetes trial

FILE PHOTO: The Eli Lilly logo is shown at the BIO International Convention 2026, a meeting of pharmaceutical and biotechnology leaders in San Diego, California, U.S. June 23, 2026.

FILE PHOTO: The Eli Lilly logo is shown at the BIO International Convention 2026, a meeting of pharmaceutical and biotechnology leaders in San Diego, California, U.S. June 23, 2026. (REUTERS/Mike Blake/File Photo)


1 photo
Save Story

Estimated read time: Less than a minute

Sept 29 — ​Eli Lilly said ‌on Tuesday ⁠its ​experimental ⁠drug ‌helped adults ‌with type ⁠2 ⁠diabetes and obesity lose an ‌average ​of nearly 21% of their body ​weight ‌in ‌a late-stage ⁠clinical trial.

(Reporting by Kamal ‌Choudhury ​in ‌Bengaluru; ⁠Editing ​by Shilpi ​Majumdar)

Photos

Most recent Lifestyle stories

Related topics

STAY IN THE KNOW

Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Notice.
Newsletter Signup

KSL Weather Forecast

KSL Weather Forecast
Play button